UPDATE 1-Jilted Shire raises guidance again after Q3 earnings jump
October 24, 2014 at 07:22 AM EDT
LONDON, Oct 24 (Reuters) - Pharmaceutical firm Shire raised its guidance for full-year earnings on Friday, underlining its strong prospects as a standalone company after AbbVie Inc officially ditched its $55 billion purchase of the group on Tuesday.
